The move comes as the company looks to increase its focus on its ex vivo cell therapy product line. In November, the company cut 15 percent of its 500-person staff, GeekWire reported Oct. 10. The company did not report the exact number of workers affected in this round of layoffs.
As of June 30, the company said it had $325.9 million in cash, down from the $434 million it had reported a year earlier. The company, which went public in 2021, said that it would continue development of its Bothell, Wash.-based manufacturing facility.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
